Follow The Filings

SER Serina Therapeutics

Serina Therapeutics earnings company data as of 4:48 AM ET 10/23

History

2 periods, newest first. Each row shows EPS above revenue.

Period Date Metric Estimate Actual Result
FY2026 Q3 12 Nov EPS — — —
Rev — — —
FY2026 Q2 13 Aug EPS — -0.55 —
Rev — — —

Insider trades

Open-market buys and sales by SER's executives, directors and 10% owners in the last 12 months, from their Form 4s

All SER insider trades
  • $78K bought by 4 insiders
  • None no sales outside a trading plan
  • $447K sold by 1 insider under 10b5-1 plans
  1. Stephen K. Brannan Director
    Buy
    $2,030 1,000 shares at $2.03 New stake
    Traded Jul 7 Filed Jul 9
    ↗
  2. Jay Venkatesan Director
    Buy
    $1,048 589 shares at $1.78 New stake
    Traded May 22 Filed Jun 22
    ↗
  3. Karen J Wilson Director
    Buy
    $18K 10,100 shares at $1.76 New stake
    Traded Jun 11–12 Filed Jun 15
    ↗
  4. Karen J Wilson Director
    Buy
    $37K 20,000 shares at $1.85 New stake
    Traded May 21–22 Filed May 26
    ↗
  5. Richard Peter Marshall Director
    Buy
    $20K 12,183 shares at $1.65 New stake
    Traded May 19 Filed May 22
    ↗
  6. Randall Moreadith Chief Scientific Officer
    Planned sale
    $19K 6,500 shares at $2.86 100% of stake
    Traded Mar 23 Filed Mar 24
    ↗
  7. Randall Moreadith Chief Scientific Officer
    Planned sale
    $98K 39,000 shares at $2.50 100% of stake
    Traded Mar 19 Filed Mar 20
    ↗
  8. Randall Moreadith Chief Scientific Officer
    Planned sale
    $20K 6,500 shares at $3.03 100% of stake
    Traded Feb 2 Filed Feb 3
    ↗
  9. Randall Moreadith Chief Scientific Officer
    Planned sale
    $23K 6,500 shares at $3.57 100% of stake
    Traded Jan 28 Filed Jan 29
    ↗
  10. Randall Moreadith Chief Scientific Officer
    Planned sale
    $7,375 2,500 shares at $2.95 100% of stake
    Traded Jan 22 Filed Jan 23
    ↗
  11. Randall Moreadith Chief Scientific Officer
    Planned sale
    $12K 4,000 shares at $3.04 100% of stake
    Traded Jan 20–21 Filed Jan 21
    ↗
  12. Randall Moreadith Chief Scientific Officer
    Planned sale
    $16K 6,500 shares at $2.50 100% of stake
    Traded Jan 13–14 Filed Jan 14
    ↗
  13. Randall Moreadith Chief Scientific Officer
    Planned sale
    $35K 13,000 shares at $2.69 100% of stake
    Traded Jan 8 Filed Jan 9
    ↗
  14. Randall Moreadith Chief Scientific Officer
    Planned sale
    $11K 4,100 shares at $2.60 100% of stake
    Traded Dec 23, 2025 Filed Dec 29, 2025
    ↗
  15. Randall Moreadith Chief Scientific Officer
    Planned sale
    $15K 5,673 shares at $2.67 100% of stake
    Traded Dec 22, 2025 Filed Dec 23, 2025
    ↗

Also filed in the last 12 months, not counted as buying or selling: 26 option exercises, 4 stock grants, and 3 conversions.

SEC filings

Recent issuer filings from EDGAR, 20 shown.

Filed Form Detail Links
8-K 5.03,9.01 Filing Doc
8-K 8.01,9.01 Filing Doc
8-K 1.01,3.02,9.01 Filing Doc
S-1 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 5.02,9.01 Filing Doc
SCHEDULE 13D/A — Filing Doc
8-K 5.02 Filing Doc
8-K 5.03,5.07 Filing Doc
10-Q Filing Doc
8-K 2.02,9.01 Filing Doc
SCHEDULE 13G — Filing Doc
DEFA14A Filing Doc
DEF 14A Filing Doc
8-K 5.02,5.03 Filing Doc
10-K/A Filing Doc
10-K Filing Doc
8-K 2.02,9.01 Filing Doc
8-K 1.01,3.02,5.02,5.03,7.01,9.01 Filing Doc

Source: SEC EDGAR submissions, updated 5 days ago. All on EDGAR

Estimates are consensus figures; SEC filings remain the official record. Not investment advice.